Please provide your email address to receive an email when new articles are posted on . Using extracorporeal life support early did not reduce death risk at 30 days in patients with MI and cardiogenic ...
Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes
The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal membrane oxygenation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results